Amanta Healthcare Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter
- September 9, 2026
- Posted by: Harsh Piplani
- Category: Results
Amanta Healthcare share price Rs 205.89 on 9 September 2026, up 2.00%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 3.31 crore. Q2 FY26 base a profit of Rs 1.21 crore.
Quick Answer
The Amanta Healthcare Q2 results date for FY27 is not confirmed, and Amanta Healthcare Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 70.89 crore in revenue and a profit of Rs 1.21 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.
The Amanta Healthcare Q2 results FY27 announcement is the next scheduled earnings event for Amanta Healthcare Ltd., a maker of sterile liquid parenteral products including intravenous fluids, diluents and ophthalmic and respiratory solutions. The stock traded at Rs 205.89 on the NSE on 9 September 2026, up 2.00% from the previous close of Rs 201.86, about 0.1% below its 52-week high of Rs 206.00 and 123.8% above its 52-week low of Rs 92.00.
What makes the Amanta Healthcare Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 70.89 crore of revenue and a profit of Rs 1.21 crore, while the most recent quarter on record, Q1 FY27, produced Rs 68.80 crore and a profit of Rs 3.31 crore. Everything below is built from those reported figures rather than from any forecast.
Click Here – Get Free Investment Predictions
When Is the Amanta Healthcare Q2 Results FY27 Date?
The Amanta Healthcare Q2 results date for FY27 is not confirmed. As of 9 September 2026, Amanta Healthcare Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.
What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Amanta Healthcare Q2 results date becomes public through that filing rather than through any advance announcement.
The Amanta Healthcare Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Amanta Healthcare.
Amanta Healthcare Q2 Results Expectations: What the Market Is Actually Tracking
No verified analyst estimate for the Amanta Healthcare Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Amanta Healthcare. The Amanta Healthcare Q2 results watchlist below is built from what the company has actually reported and disclosed.
The first is that the September 2025 profit of Rs 1.21 crore was not an operating problem. Operating profit that quarter was Rs 14.65 crore, in line with the other four, and the profit fell because of negative other income and a 46.93% tax charge.
The second is margin consistency. Operating margin held between 19.43% and 22.81% across all five quarters, so the September 2026 result should turn on revenue and on what sits below the operating line rather than on margin.
The third is the interest cost. Borrowings of about Rs 244 crore against equity of roughly Rs 220 crore mean interest of Rs 4 crore to Rs 6 crore a quarter absorbs close to a third of operating profit before anything else.
Check Amanta Healthcare Ltd. Live Fundamentals on the Univest Screener
Amanta Healthcare Q2 Results Preview: The Q1 FY27 Actuals It Builds On
Amanta Healthcare Ltd. reported revenue of Rs 68.80 crore in Q1 FY27, up 5.34% from Rs 65.31 crore in Q1 FY26, and a profit of Rs 3.31 crore at the net level, down 5.70% from Rs 3.51 crore in Q1 FY26. These are reported actuals, not estimates.
Sequentially, revenue was down 10.64% over the March 2026 quarter figure of Rs 76.99 crore, and net profit was down 40.14% from Rs 5.53 crore in Q4 FY26. Operating margin stood at 21.13% in Q1 FY27 against 20.67% in the September 2025 quarter, which is the comparison the Amanta Healthcare Q2 results print will be read against.
Q2 FY26 Base: The Comparison Amanta Healthcare Q2 Results FY27 Must Beat
Amanta Healthcare Ltd. reported revenue of Rs 70.89 crore and a profit of Rs 1.21 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Amanta Healthcare Q2 results preview.
Net profit in that base quarter was below the Rs 3.31 crore just reported for Q1 FY27, so the year-on-year comparison starts from a manageable level. Revenue of Rs 70.89 crore sits above the Rs 68.80 crore of the June 2026 quarter, which frames how much sequential movement the Amanta Healthcare Q2 results print needs to show growth.
Amanta Healthcare Quarterly Results Trend Over the Last Four Quarters
| Quarter | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q2 FY26 (Sep 2025) | 70.89 | 1.21 |
| Q3 FY26 (Dec 2025) | 74.49 | 4.63 |
| Q4 FY26 (Mar 2026) | 76.99 | 5.53 |
| Q1 FY27 (Jun 2026) | 68.80 | 3.31 |
Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company’s exchange filings, and they are the only basis this Amanta Healthcare Q2 results preview uses.
Revenue across those four quarters ranged from Rs 68.80 crore to Rs 76.99 crore, and net profit from Rs 1.21 crore to Rs 5.53 crore. That spread is the honest context for the Amanta Healthcare Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.
Key Factors That Could Shape Amanta Healthcare Q2 Results FY27
The Amanta Healthcare Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Amanta Healthcare has already reported.
Below the Operating Line
This is a company where operating profit has been steady and reported profit has not. Interest, other income and the tax charge explain the difference, and all three are disclosed in the quarterly filing.
Capacity Expansion and Utilisation
Sterile fluid manufacturing is capital intensive and margin depends on how full the lines run. New capacity funded by borrowings raises both the depreciation and the interest charge before it raises revenue.
Earnings Per Share Not Comparable
The share count rose about a third between June 2025 and June 2026 following the September 2025 listing, so the fall in earnings per share over that period does not reflect a fall in profit. Net profit is the figure to compare.
Amanta Healthcare Q2 Results FY27: Share Price and Valuation Going Into the Print
Amanta Healthcare share price today is Rs 205.89 on the NSE, up Rs 4.03 or 2.00% from the previous close of Rs 201.86 on 9 September 2026, ahead of the Amanta Healthcare Q2 results announcement.
| Metric | Value (9 September 2026) |
|---|---|
| NSE Symbol | AMANTA |
| Current Market Price | Rs 205.89 |
| 52-Week High | Rs 206.00 |
| 52-Week Low | Rs 92.00 |
| Market Capitalisation | Rs 795.48 crore |
| PE Ratio | 51.89 |
| PB Ratio | 3.63 |
| EPS (TTM) | Rs 3.97 |
| Book Value per Share | Rs 56.70 |
| Debt to Equity | 1.11 |
| Return on Equity | 10.30% |
| 50-Day Moving Average | Rs 175.40 |
| 200-Day Moving Average | Rs 131.33 |
| RSI (14) | 64.57 |
The stock trades above both its 50-day average of Rs 175.40 and its 200-day average of Rs 131.33, with a 14-day RSI of 64.57. None of this is a view on where the shares go once the Amanta Healthcare Q2 results are announced, and no price target is offered here.
Download the Univest iOS App or Univest Android App to track Amanta Healthcare Ltd. live price and quarterly earnings updates.
What Investors Should Watch When Amanta Healthcare Q2 Results Are Announced
Four lines carry most of the information in a company of this size, and reading them in order keeps the Amanta Healthcare Q2 results print in proportion.
- Revenue against the Rs 70.89 crore reported in the September 2025 base quarter
- Net profit against a profit of Rs 1.21 crore in that same quarter
- Operating margin against 21.13% in Q1 FY27
- Any exceptional item, provision or one-off gain disclosed alongside the numbers
A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Amanta Healthcare Q2 results announcement should be read together with the notes to the results rather than the headline alone.
Conclusion on Amanta Healthcare Q2 Results FY27
The Amanta Healthcare Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Amanta Healthcare Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.
On that basis the Amanta Healthcare Q2 results FY27 print faces a base of Rs 70.89 crore in revenue and a profit of Rs 1.21 crore, with the most recent quarter having delivered Rs 68.80 crore and a profit of Rs 3.31 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Amanta Healthcare, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Amanta Healthcare Q2 Results FY27
What is the Amanta Healthcare Q2 results date for FY27?
Ans. The Amanta Healthcare Q2 results date for FY27 is not confirmed. Amanta Healthcare Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.
What quarter do the Amanta Healthcare Q2 results 2026 cover?
Ans. The Amanta Healthcare Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Amanta Healthcare Ltd. reports revenue, operating profit and net profit for that period, and the Amanta Healthcare Q2 results filing also carries the notes to the accounts.
What were the Amanta Healthcare Q1 FY27 results?
Ans. Amanta Healthcare Ltd. reported revenue of Rs 68.80 crore in Q1 FY27 and a profit of Rs 3.31 crore at the net level. Revenue was up 5.34% versus Q1 FY26 and net profit was down 5.70% from Rs 3.51 crore in Q1 FY26.
What were Amanta Healthcare Q2 FY26 results in the September 2025 quarter?
Ans. Amanta Healthcare Ltd. reported revenue of Rs 70.89 crore and a profit of Rs 1.21 crore in Q2 FY26. Operating margin was 20.67%. Those figures form the base for the Amanta Healthcare Q2 results FY27 comparison.
What are the main Amanta Healthcare Q2 results expectations this quarter?
Ans. No verified analyst estimate is publicly available. The Amanta Healthcare Q2 results expectations centre on revenue against the Rs 70.89 crore base, net profit against a profit of Rs 1.21 crore, operating margin against 21.13% in Q1 FY27, and any exceptional item disclosed with the numbers.
What is Amanta Healthcare share price today ahead of the Q2 earnings?
Ans. Amanta Healthcare share price is Rs 205.89 on the NSE as of 9 September 2026, up 2.00% from Rs 201.86. The stock is about 0.1% below its 52-week high of Rs 206.00 and 123.8% above its 52-week low of Rs 92.00, at a market capitalisation of Rs 795.48 crore.
Is Amanta Healthcare a good stock to buy before the Q2 results?
Ans. This article does not offer a buy, sell or hold recommendation on Amanta Healthcare Ltd.. The stock trades at a price-to-book ratio of 3.63 with a return on equity of 10.30%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.
